Virology and Immunology of Gene Therapy 2025
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 243
Special Issue Editors
Interests: gene therapy; AAV; tissue tropism; vector; hemophilia
Special Issues, Collections and Topics in MDPI journals
Interests: parvovirus; DNA replication; mRNA processing; antiviral; virus receptor; gene therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The interplay between virology, immunology, and gene therapy is a dynamic and critical area of research. Virology provides the tools and vectors for gene therapy, immunology ensures these tools are safely and effectively accepted by the body, and gene therapy offers new ways to treat diseases by harnessing and modifying these biological systems. Therefore, we have created a Special Issue to address the most important scientific areas:
- Development of efficient viral vectors;
- Development of new vector production technology to reduce potential immune responses;
- Better vector characterization technology;
- Immunogenicity of viral vectors;
- Immunotherapy using gene therapy;
- Overcoming pre-existing immunity;
- Gene editing for immune modulation;
- Autoimmune diseases and gene therapy;
- Viral vector-based vaccines.
Prof. Dr. Weidong Xiao
Prof. Dr. Jianming Qiu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gene therapy
- viral vector
- vaccine
- immune responses
- viruses
- AAV
- lentiviral vectors
- neutralizing antibody
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- Virology and Immunology of Gene Therapy in Viruses (4 articles)
